Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study - Top-Institutions - MDSpire

Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study

  • By

  • Isabel Leroux-Roels

  • Azhar Alhatemi

  • Magalie Caubet

  • Fien De Boever

  • Bertrand de Wergifosse

  • Mohamed El Idrissi

  • Guilherme S Ferreira

  • Bart Jacobs

  • Axel Lambert

  • Sandra Morel

  • Charlotte Servais

  • Juan Pablo Yarzabal

  • October 24, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of Oxford
    University of Oxford

    Oxford, Oxfordshire

    Key Differentiators

    • Infectious Diseases
    • Vaccine Research
    • Immunology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Infectious Diseases
    • Microbiology
    • Vaccine Development

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, California

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Clinical Trials

  • #4

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, Georgia

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Research

  • #5

    GlaxoSmithKline (GSK) Vaccines
    GlaxoSmithKline (GSK) Vaccines

    Rixensart, Belgium

    Key Differentiators

    • Vaccine Development
    • Immunology
    • Clinical Trials

Original Source(s)

Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study

  • by Isabel Leroux-Roels, Azhar Alhatemi, Magalie Caubet, Fien De Boever, Bertrand de Wergifosse, Mohamed El Idrissi, Guilherme S Ferreira, Bart Jacobs, Axel Lambert, Sandra Morel, Charlotte Servais, Juan Pablo Yarzabal

  • October 24, 2024

Related Content

Microbiome analysis and fecal microbiota transfer in pediatric gastroenterology — a structured online survey in German-speaking countries

Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis

Amoxicillin-clavulanate was not linked to lower treatment failure but was associated with a slightly higher risk of secondary infections compared with amoxicillin in adults with uncomplicated acute sinusitis.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.